TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS

针对特定病毒感染的有针对性的临床研究

• 批准号: 9467404
• 负责人: DAVID KIMBERLIN
• 金额: $ 260.87万
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-07-01 至 2021-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9467404
• 关键词: Address; Advanced Development; Childhood; Clinical Course of Disease; Clinical Research; Cytomegalovirus Infections; Emerging Communicable Diseases; Medical; Population; Research; Therapeutic; Virus Diseases; patient population; therapeutic development

To advance the development of therapeutic strategies for rare and/or emerging viral diseases of medical importance in targeted patient populations by 1) characterizing contemporary course of the clinical disease, and/or 2) directly evaluating a therapy.

通过1)描述临床疾病的当代病程，和/或2)直接评估一种治疗方法，推动针对目标患者群体中具有医学重要性的罕见和/或新出现的病毒疾病的治疗策略的开发。